PATIENTS WITH RECURRENT HCV INFECTION AND UNDER ANGIOTENSIN RECEPTOR BLOCKERS AFTER LIVER TRANSPLANTATION HAVE SLOWER HISTOLOGICAL PROGRESSION

被引：0
|
作者：
Cholongitas, E. [2 ,3 ]
Quaglia, A. [1 ]
Samonakis, D. [2 ,3 ]
Manousou, P. [2 ,3 ]
Papatheodoridis, G. [2 ,3 ]
Senzolo, M. [2 ,3 ]
Patch, D. [2 ,3 ]
Dhillon, A. [1 ]
Burroughs, A. [2 ,3 ]
机构：
[1] Royal Free Hosp, Dept Histopathol, London NW3 2QG, England
[2] Royal Free Hosp, Dept Surg, London NW3 2QG, England
[3] Royal Free Hosp, Royal Free Sheila Sherlock Liver Ctr, London NW3 2QG, England
来源：
JOURNAL OF HEPATOLOGY | 2009年 / 50卷
关键词：
D O I：
10.1016/S0168-8278(09)60455-4
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
453
引用
收藏
页码：S171 / S171
页数：1
相关论文
共 50 条
  • [31] MMF treatment in patients with HCV reinfection after liver transplantation: Influence on clinical course and histological damage
    Langrehr, JM
    Bahra, M
    Neumann, UP
    Neuhaus, R
    Neuhaus, P
    LIVER TRANSPLANTATION, 2003, 9 (06) : C44 - C44
  • [32] The Clinical Significance of SVR in Patients with Cirrhosis Due to Recurrent HCV infection Post Orthotopic Liver Transplantation
    Kwo, Paul Y.
    Ghabril, Marwan
    Lacerda, Marco A.
    Agrawal, Saurabh
    HEPATOLOGY, 2013, 58 : 1051A - 1051A
  • [33] Analysis of a successful HCV-specific CD8+ T cell response in patients with recurrent HCV-infection after liver transplantation (OLTX)
    Gruener, NH
    Ulsenheimer, A
    Jung, MC
    Gerlach, JT
    Zachoval, R
    Diepolder, HM
    Baretton, G
    Schauer, R
    Pape, GR
    Schirren, CA
    JOURNAL OF HEPATOLOGY, 2004, 40 : 6 - 6
  • [34] Analysis of a successful HCV-specific CD8+ T cell response in patients with recurrent HCV-infection after orthotopic liver transplantation
    Gruener, NH
    Jung, MC
    Ulsenheimer, A
    Gerlach, JT
    Zachoval, R
    Diepolder, HM
    Baretton, G
    Pape, GR
    Schirren, CA
    LIVER TRANSPLANTATION, 2004, 10 (12) : 1487 - 1496
  • [35] IL28B POLYMORPHISMS ARE ASSOCIATED WITH HISTOLOGICAL RECURRENCE AND TREATMENT RESPONSE FOLLOWING LIVER TRANSPLANTATION IN PATIENTS WITH HCV WITH HCV INFECTION
    Charlton, Michael R.
    Thompson, Alexander J.
    Veldt, Bart J.
    Watt, Kymberly D.
    Tillmann, Hans L.
    Poterucha, John J.
    Heimbach, Julie
    Goldstein, David B.
    McHutchison, John G.
    HEPATOLOGY, 2010, 52 (04) : 320A - 320A
  • [36] Histological benefit of retreatment by pegylated-IFN and ribavirin in patients with recurrent hepatitis HCV infection post-transplantation
    Bizollon, T.
    Pradat, P.
    Mabrut, J.
    Ducerf, C.
    Souquet, J.
    Trepo, C.
    JOURNAL OF CLINICAL VIROLOGY, 2006, 36 : S182 - S182
  • [37] Fibrosis progression in patients with recurrent chronic hepatitis C virus and occult hepatitis BCo-infection after liver transplantation
    Hui, Chee-Kin
    Lau, Eva
    Kim, Michael
    Monto, Alexander
    Luk, John M.
    Leung, Nancy
    Lo, Chung-Mau
    Fan, Sheung-Tat
    Wright, Teresa L.
    Lau, George K. K.
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2006, 21 : A80 - A81
  • [38] Genetic similarity of hepatitis C virus and fibrosis progression in chronic and recurrent infection after liver transplantation
    López-Labrador, FX
    Bracho, MA
    Berenguer, M
    Coscollà, M
    Rayón, JM
    Prieto, M
    Carrasco, D
    Gómez, MD
    Moya, A
    González-Candelas, F
    JOURNAL OF VIRAL HEPATITIS, 2006, 13 (02) : 104 - 115
  • [39] Efficacy of interferon in immunocompromised HCV patients after liver transplantation or with HIV co-infection
    Reiberger, T.
    Rasoul-Rockenschaub, S.
    Rieger, A.
    Ferenci, P.
    Gangl, A.
    Peck-Radosavljevic, M.
    EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 2008, 38 (06) : 421 - 429
  • [40] Prospective randomized trial on early treatment of HCV infection after liver transplantation in HCV-RNA positive patients
    Mazzaferro, V
    Schiavo, M
    Caccamo, L
    Tagger, A
    Morabito, A
    Lavezzo, B
    Antonucci, A
    Bonino, F
    LIVER TRANSPLANTATION, 2003, 9 (06) : C36 - C36
12345